Abstract
Choline phosphoglycerides (CPG) represent the major fraction of heart phospholipids. Since depletion of membrane phospholipids and accumulation of lyso-compounds, particularly lysophosphatidylcholines, have been implicated in arrhythmogenesis, it was of great interest to study the composition of this major phospholipid fraction of the heart at a molecular level in an established animal model. The data presented here describe the first report on the detailed chemical examination of CPG and resolution, characterization and quantitative analysis of the molecular species of this phospholipid fraction from porcine heart by high performance liquid chromatography (HPLC). This fraction constitutes 37.5 ± 0.7% (n = 21) of the total phospholipids and upon successive mild acid and alkaline hydrolyses revealed the presence of essentially three subclasses: diacyl-, alkenylacyl-, and alkylacyl glycerophosphorylcholines, in a relative abundance of 57.7 ± 2.2% (n = 8), 37.3 ± 1.3% (n = 8) and 4.6 ± 0.2% (n = 8), respectively. The fourth subclass, dialkyl CPG was found only in minute amounts (0.43 ± 0.05%, n = 8) and the presence of dialkenyl and alkenylalkyl analogues could not be detected. Alternatively, by converting the CPG fraction to benzoate derivatives after phospholipase C digestion, it was possible to isolate and quantitate subclass composition by TLC/spectroscopy or both subclass compositions and molecular species analysis by HPLC directly by a UV detector online with the column. By these techniques, subclass composition was found to be very similar to that obtained by the chemical hydrolysis technique. By HPLC, up to 25 species can be identified and quantitated in each subclass, their identity being confirmed by gas-liquid chromatography, after their isolation from the column. The analyses showed that up to 74% of the diacyl moiety consisted of 16:0–18:2 (34%), 16:0–18:1 (27%), and 18:0–18:2 (13%) species, while the major species of the alkenylacyl moiety were 16:0–18:2 (44%) 16:0–18:1 (13%), 16:0–20:4 (12%) and 18:1–18:2 (9%) making up more than 75% of the total mass of this subclass. The major molecular species of the alkylacyl moiety was 16:0–18:2, constituting up to 47% of this fraction, while others constituted about 10% (16:0–18:1), 9% (18:1–18:2), 8% (16:0–20:4) and 6% (18:0–18:2), making up 80% of the total mass.
The ether chain composition of alkylacyl CPG whether determined after isolation of this fraction by the chemical hydrolysis technique or by HPLC was indistinguishable. Similarly, the aliphatic moieties of diradylglycerols, and their subclasses, whether analysed directly or reconstituted from the molecular species data, were very similar in composition, confirming the accuracy of the data and the reproducibility of the technique devised. This also suggests that this method is suitable to distinguish minor changes in the molecular species of CPG in the heart during the early phase of ischemia and in arrhythmias, and should facilitate further studies on the metabolism of the individual species in health and disease.
Similar content being viewed by others
References
Hanahan DJ, Nelson DR: Phospholipids as dynamic participants in biological processes. J Lipid Res 25: 1528–1534, 1984
Spector AA, Yorek MA: Membrane lipid composition and cellular function. J Lipid Res 26: 1015–1035, 1985
Shaikh NA, Downar E: Activation of phospholipases during myocardial ischemia and their probable role in arrhythmogenesis. In: HL Stone and WB Weglicki (eds) Pathobiology of Cardiovascular Injury. Martinus Nijhoff Pulbishing, Boston, 1985, pp 298–316
Katz AM, Messineo FC: Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Cite Res 48: 1–16, 1981
Sobel BE, Corr PB: Biochemical mechanisms potentially responsible for lethal arrhythmias induced by ischemia: The lysolipid hypothesis. Adv Cardiol 26: 76–85, 1979
Shaikh NA, Downar E: Time Course of Changes in Porcine Myocardial Phospholipid Levels during Ischemia. Cite Res 49: 316–325, 1981
Chien DR, Reeves JP, Buja LM, Bonte F, Parkey RW, Willerson JT: Phospholipid alterations in canine ischemic myocardium. Circ Res 48: 711–719, 1981
Chien KR, Pfau RG, Farber IL: Ischemic myocardial cell injury: Prevention by chlorpromazine of an accelerated phospholipid degradation and associated membrane dysfunction. Am J Pathol 97: 505–529, 1979
Langer GA, Frank JS, Philipson KD: Correlation of alterations in cation exchange and sarcolemmal ultrastructure produced by neuraminidase and phospholipases in cardiac cell tissue culture. Circ Res 49: 1289–1299, 1981
Corr PB, Cain ME, Witkowski FX, Price DA, Sobel BE: Potential arrhythmogenic electrophysiological derangements in canine Purkinje fibers induced by lysophosphoglycerides. Cire Res 44(6): 822–832, 1979
Man RYK, Choy PC: Lysophosphatidylcholine causes cardiac arrhythmias. J Mol Cell Cardiol 14(3): 173–175, 1982
Holub B, Kuksis A: Metabolism of molecular species of diacylglycerophospholipids. Adv Lipid Res 16: 1–125, 1978
Purdon AD, Patelunds D, Smith JB: Resolution of radiolabeled molecular species of phospholipid in human platelets: Effect of thrombin. Lipids 22: 116–120, 1987
Takamura H, Narita H, Urade R, Kito M: Quantitative analysis of polyenoic phospholipid molecular species by high performance liquid chromatography. Lipids 21: 356–361, 1986
Takamura H, Narita H, Park HJ, Tanaka K, Matsuura T, Kito M: Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen. J Biol Chem 262: 2262–2269, 1987
Akino T, Ohno K: Phospholipids of the lung in normal, toxic, and diseased states. I: Physiological significance of lung phospholipids. CRC Crit Rev in Toxicol 9(3): 201–274, 1981
Hermetter A, Paltauf F: Permeability properties of unilamellar vesicles containing choline plasmalogens and comparison with other choline glycerophospholipid species. Chem Phys Lipids 29: 225–233, 1981
Gudbjarnason S, Oskarsdottir G, Doell B, Hallgrimsson J: Myocardial membrane lipids in relation to cardiovascular disease. Adv Cardiol 25: 139–144, 1978
Chambaz J, Pepin D, Robert A, Wolf C, Bereziat G: Protein-stimulated enrichment of human platelet membranes in linoleylphosphatidylcholines: Effect upon adenylate cyclase and fluidity. Biochim Biophys Acta 727: 313–326, 1983
Irvine RF: How is the level of free arachidonic acid controlled in mammarian cells? Biochem J 204: 3–16, 1982
Swendsen CL, Ellis JM, Chilton FH III, O'Flaherty JT, Wykle RL: 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: A novel source of arachidonic acid in neutrophils stimulated by the calcium ionophore A23187. Biochem Biophys Res Commun 113: 72–79, 1983
Itch K, Natori H, Suzuki A, Akino T: Differentiation of primary or metastatic lung carcinoma by phospholipid analysis. A new approach for lung carcinoma differentiation. Cancer (Philadelphia) 57: 1350–1357, 1986
Taylor IM, Shaikh NA, Downar E: Ultrastructural changes of ischemic injury due to coronary artery occlusion in the porcine heart. J Mol Cell Cardiol 16: 79–94, 1984
Shaikh NA, Palmer FB: Deposition of lipids in the developing central and peripheral nervous systems of the chicken. J Neurochem 26: 597–603, 1976
Pugh EL, Kates M, Hanahan DJ: Characterization of alkyl ether species of phosphatidylcholine in bovine heart. J Lipid Res 18: 710–716, 1977
Arvidson GAE: Structural and metabolic heterogencity of rat liver glycerophosphatides. Eur J Biochem 4: 478–486, 1968
Blank ML, Cress EA, Piantadosi C, Snyder F: A method for the quantitative determination of glycerolipids containing O-alkyl and O-alk-1-enyl moieties. Biochim Biophys Acta 380: 208, 1975
Wood R: GLC and TLC analysis of isopropylidene derivatives of isomeric polyhydroxy acids derived from positional and geometrical isomers of unsaturated fatty acids. Lipids 2: 199, 1967
Blank ML, Robinson M, Fitzgerald V, Snyder F: Novel quantitative method for determination of molecular species of phospholipids and diglycerides. J Chromatogr 298: 473–482, 1984
Nakagawa Y, Horrocks LA: Separation of alkenylacyl, alkylacyl, and diacyl analogues and their molecular species by high performance liquid chromatography. J Lipid Res 24: 1268–1275, 1983
Porter NA, Wolf Ra, Nixon JR: Separation and purification of lecithins by high pressure liquid chromatography. Lipids 14(1): 20–24, 1979
Robins SJ, Patton GM: Separation of phospholipid molecular species by high performance liquid chromatography: potentials for use in metabolic studies. J Lipid Res 27: 131–139, 1986
Smith M, Monchamp P, Jungalwala FB: Separation of molecular species of sphingomyelin and ceramide by argentation and reversed-phase HPLC. J Lipid Res 22: 714–719, 1981
Hsieh JY-K, Welch DK, Turcotte JG: High pressure liquid chromatographic separation of molecular species of phosphatidic acid dimethyl esters derived from phosphatidylcholine. Lipids 16: 761–763, 1981
Nakagawa Y, Waku K: Separation of the molecular species of diacyl and alkenylacyl subclasses of the methyl ester of dinitrophenylethanolamine glycerophospholipid by high-performance liquid chromatography. J Chromatogr 487: 239–245, 1989
Gray GM: The phospholipids of ox spleen with special reference to the fatty acid and fatty aldehyde compositions of the lecithin and kephalin fractions. Biochem J 77: 2–91, 1960
Warner HR, Lands WEM: Metabolism of plasmalogen. II. The determination of alkenyl ethers in the presence of free aldehydes. J Lipid Res 4: 216–220, 1963
Gross RW: Identification of plasmalogen as the major phospholipid constituent of cardiac sarcoplasmic reticulum. Biochemistry 24: 1662–1668, 1985
Myher JJ, Kuksis A: Resolution of alkenylacylglycerol moieties of natural glycerophospholipids by gas-liquid chromatography on polar capillary columns. Can J Biochem 62: 352–362. 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shaikh, N.A. Characterization and analysis of the subclasses and molecular species of choline phosphoglycerides from porcine heart by successive chemical hydrolyses and reverse phase high-performance liquid chromatography. Mol Cell Biochem 96, 43–55 (1990). https://doi.org/10.1007/BF00228452
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00228452